Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine
Yuxin Chen, Shengxia Yin, Xin Tong, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 3, pp. 410-418
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
Jing Lian Suah, Masliyana Husin, Peter Seah Keng Tok, et al.
International Journal of Infectious Diseases (2022) Vol. 119, pp. 69-76
Open Access | Times Cited: 67
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 64
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100793-100793
Open Access | Times Cited: 57
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants
Yuxin Chen, Lin Chen, Shengxia Yin, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1524-1536
Open Access | Times Cited: 48
Waning antibody levels after COVID-19 vaccination with mRNA Comirnaty and inactivated CoronaVac vaccines in blood donors, Hong Kong, April 2020 to October 2021
Shirley L. L. Kwok, Samuel M. S. Cheng, Jennifer NS Leung, et al.
Eurosurveillance (2022) Vol. 27, Iss. 2
Open Access | Times Cited: 42
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 33
T cell immune memory after covid-19 and vaccination
Lulu Wang, Alexander R. Nicols, Lance Turtle, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000468-e000468
Open Access | Times Cited: 27
Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh
Md. Ahsanul Haq, Anjan Kumar Roy, Razu Ahmed, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients
Yuxin Chen, Tiantian Zhao, Lin Chen, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 5
In-depth immunochemical characterization of the serum antibody response using a dual-titration microspot assay
Ágnes Melinda Kovács, Zoltán Hérincs, Krisztián Papp, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine
Xiuwen Wang, Xiaodong Yang, Xin Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Incidence of dynamic seroconversion in subjects received the first dose of the SARS-COV-2 vaccine (AstraZeneca, Moderna and Pfizer) in Kinshasa, Democratic Republic of Congo: prospective cohort study
Eric Kasongo Mukenge, Blaise Matondo Manzambi Sumbu, Aliocha Natuhoyila Nkodila, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination
Ayman Al Jurdi, Rodrigo Benedetti Gassen, Thiago J. Borges, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals
Rongzhang He, Xingyu Zheng, Jian Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 14
CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
Keywan Mortezaee, Jamal Majidpoor
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Comparing T- and B-cell responses to COVID-19 vaccines across varied immune backgrounds
Zhen Cui, Wenxin Luo, Ruihong Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19
Marina Mazzilli Ortega, Laís Teodoro da Silva, Erika Donizette Candido, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Longitudinal proteomic investigation of COVID-19 vaccination
Yingrui Wang, Qianru Zhu, Rui Sun, et al.
Protein & Cell (2023) Vol. 14, Iss. 9, pp. 668-682
Open Access | Times Cited: 8
Ad5‐nCoV booster and Omicron variant breakthrough infection following two doses of inactivated vaccine elicit comparable antibody levels against Omicron variants
Weiya Kong, Qingyang Zhong, Mingxiao Chen, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 13
Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight
Qian Zhu, Yingzhi Zhang, Juan Kang, et al.
Genes & Diseases (2022) Vol. 10, Iss. 2, pp. 608-617
Open Access | Times Cited: 13
Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences
Maria Madeleine Rüthrich, Nicola Giesen, Sibylle C. Mellinghoff, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 182-182
Open Access | Times Cited: 12
Humoral Immune Response of BNT162b2 and CoronaVac Vaccinations in Hemodialysis Patients: A Multicenter Prospective Cohort
René Clavero, Alfredo Parra-Lucares, Gabriel Méndez-Valdés, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1542-1542
Open Access | Times Cited: 12
T-Cell Epitope Mapping of SARS-CoV-2 Reveals Coordinated IFN-γ Production and Clonal Expansion of T Cells Facilitates Recovery from COVID-19
Xing Fan, Jin‐Wen Song, Wen-Jing Cao, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 2
Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice
Anran Shen, Xiaoxiao Jin, Tao‐Tao Tang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3325-3341
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top